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ABSTRACT
Objectives Increasing evidence suggests that 
inflammatory mechanisms play a key role in chronic 
tendon disease. After observing T cell signatures in 
human tendinopathy, we explored the interaction 
between T cells and tendon stromal cells or tenocytes to 
define their functional contribution to tissue remodelling 
and inflammation amplification and hence disease 
perpetuation.
Methods T cells were quantified and characterised 
in healthy and tendinopathic tissues by flow cytometry 
(FACS), imaging mass cytometry (IMC) and single cell 
RNA- seq. Tenocyte activation induced by conditioned 
media from primary damaged tendon or interleukin-
1β was evaluated by qPCR. The role of tenocytes in 
regulating T cell migration was interrogated in a standard 
transwell membrane system. T cell activation (cell surface 
markers by FACS and cytokine release by ELISA) and 
changes in gene expression in tenocytes (qPCR) were 
assessed in cocultures of T cells and explanted tenocytes.
Results Significant quantitative differences were 
observed in healthy compared with tendinopathic 
tissues. IMC showed T cells in close proximity to 
tenocytes, suggesting tenocyte–T cell interactions. On 
activation, tenocytes upregulated inflammatory cytokines, 
chemokines and adhesion molecules implicated in 
T cell recruitment and activation. Conditioned media 
from activated tenocytes induced T cell migration and 
coculture of tenocytes with T cells resulted in reciprocal 
activation of T cells. In turn, these activated T cells 
upregulated production of inflammatory mediators in 
tenocytes, while increasing the pathogenic collagen 3/
collagen 1 ratio.
Conclusions Interaction between T cells and tenocytes 
induces the expression of inflammatory cytokines/
chemokines in tenocytes, alters collagen composition 
favouring collagen 3 and self- amplifies T cell activation 
via an auto- regulatory feedback loop. Selectively 
targeting this adaptive/stromal interface may provide 
novel translational strategies in the management of 
human tendon disorders.
INTRODUCTION
Tendinopathy is the broad term encompassing 
multifactorial tendon disorders clinically char-
acterised by the presence of pain and functional 
limitation.1 Achilles, patellar and rotator cuff 
tendinopathies as well as epicondylitis are exam-
ples of this prevalent pathology that is responsible 
for up to 30% of general practice musculoskeletal 
consultations2 costing European Union healthcare 
systems in excess of €800 million annually.3
The paucity of effective treatments in tendon 
disorders partially reflects lack of understanding 
of its pathogenesis.4 Historically considered a 
degenerative pathology and therefore termed 
‘tendinosis’, research conducted during the last 
decade has revealed the presence of immune cells 
(mast cells, macrophages, T cells)5–12 and inflam-
matory cytokines (interleukin (IL)-6, IL-15, IL-17, 
IL-18, IL-33, tumour necrosis factor alpha (TNF-
α))10 11 13 14 in tendinopathic tissues. Recognition of 
this inflammatory component has important clinical 
implications, as these pathways provide therapeutic 
potential that may avoid chronicity and long- term 
complications such as pain and tendon ruptures.
During the inflammatory process there is crosstalk 
between the stromal compartment and infiltrating 
immune cells that can determine the fate of tissue 
in terms of repair or degeneration. In particular, 
Key messages
What is already known about this subject?
 ► Tendinopathy is a complex multi- faceted tendon 
pathology commonly associated with overuse. 
The potential roles of immune cells acting 
on resident tenocytes remain the source of 
some controversy while understanding these 
interactions on tendon homoeostasis is crucial 
in designing future targeted therapies.
What does this study add?
 ► Our study shows the spatial relationship of 
T cells and tenocytes in tendinopathy, an 
upregulation of inflammatory cytokines, 
chemokines and adhesion molecules in 
activated tenocytes after tendon damage, 
the effect of tenocytes on T- cell migration 
and activation and finally the impact of these 
activated T cells on the stromal compartment 
in the tendon, with the maintenance of an 
inflammatory response and changes in collagen 
3/collagen 1 ratio.
How might this impact on clinical practice or 
future developments?
 ► Selectively targeting T cells in tendinopathy 
provides scope for novel translational strategies 
in the management of tendon disorders.
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the relationship between T cells and stroma has been intensively 
studied in other rheumatic and musculoskeletal diseases, such 
as rheumatoid arthritis (RA). Chemokines involved in T cell 
recruitment are present in synovial tissues and synovial fluid 
from patients with RA15 and synovial fibroblast subsets promote 
T cell survival,16–19 activation17 20 and induce interferon (IFN)-γ, 
IL-17 and TNF-α production.20 21 In turn, T cells have reciprocal 
effects on synovial fibroblasts through upregulation of ICAM-1, 
IL-6, IL-8, IL-15, IL-18, MMP1, MMP3, PGE2, TNF-α and 
VCAM-1 in the later.17 20–23 These pathways support persistence 
of the inflammatory infiltrate, hence chronicity. However, few 
data exist regarding the relationship between tendon stromal 
cells, also known as tenocytes, and T cells and its role in the 
development of chronicity in tendinopathy.
The development of tendon inflammation focused in areas 
where tendons attach to bones, also known as enthesitis, is char-
acteristic of spondyloarthritis (SpA).24 Mechanical stress in these 
areas has been proposed as a trigger for the development of an 
inflammatory response that further extends into the synovial 
compartment. Although the presence of T cells has been observed 
at the enthesis,25 less is known about which is the relationship 
between T cells and tenocytes and its role in the development 
and perpetuation of a chronic inflammatory response in SpA.
We hypothesise that the cross- talk between tenocytes and 
T cells may play a role in the development of chronicity in 
tendon inflammation through its effect on sustaining an immune 
response by promoting migration and activation of immune 
cells and importantly, through changes collagen 3, which has 
an impact in tendon biomechanics. Herein, we analysed the 
effect of tenocytes on migration and activation of T cells and 
in turn the reciprocal effect of activated T cells on tenocytes. 
We describe a hitherto unrecognised self- amplificatory feedback 
loop in human tendon disease.
METHODS
Tissue collection and preparation
Supraspinatus and subscapularis tendon samples were collected 
from patients with rotator cuff tears undergoing shoulder 
surgery for flow cytometry (FACS) analysis, mass cytometry 
imaging and single cell RNA- sequencing. Standardised patient 
demographics were obtained preoperatively and included age, 
sex, duration of shoulder symptoms experienced by the patient 
and the number of subacromial steroid injections (table 1). 
Patients who received two steroid injections had symptoms >6 
months and had not had an injection at least 3 months prior to 
surgery. Samples of the subscapularis tendon were also collected 
from the same patients. Patients were only included if there was 
no clinically detectable evidence of subscapularis tendinopathy 
on a preoperative MRI scan as determined by a musculoskeletal 
radiologist or macroscopic damage to the subscapularis tendon 
at the time of arthroscopy as determined by the senior author 
(NLM)—by these criteria they represented a preclinical cohort. 
In this cohort, all patients fulfilled the following criteria1: a 
history of shoulder pain and dysfunction,2 no previous surgery 
on the affected shoulder,3 no radiographic sign of fracture of 
the shoulder and4 no history of RA or osteoarthritis. Hamstring 
tendons obtained at the time of routine anterior cruciate liga-
ment (ACL) reconstruction were employed as an independent 
control group. Healthy human tenocytes were explanted from 
hamstring tendon of patients undergoing ACL reconstruction. 
Cells were maintained at 37°C in a humidified atmosphere of 
5% CO2 for up to 28 days and then subcultured and trypsinised 
at subconfluency, using cells with less than four passages.
Immunophenotype of tendinopathic tissue
Tendon tissue was digested in 0.15 mg/mL Liberase TM (Sigma- 
Aldrich) in 10 mL RPMI, kept in constant rotation at 37°C for a 
maximum of 2 hours. Digested tissue was then filtered, and cells 
were stained with the following antibodies: anti- CD45 BV510 
and anti- CD3 FITC, anti- CD19 APC, anti- CD64 APC- Cy7 and 
anti- CD117 PE (Biolegend). Samples were run on an LSRII flow 
cytometer (BD Biosciences) and results analysed with FlowJo 
software. Cells were initially gated on the forward and side 
scatter (online supplemental figure 1A), following identifica-
tion of singlet cells, immune cells were gated on CD45+ events. 
Subsequently, macrophages (CD64+) and (CD3+) T Cells were 
identified, the negative population of both markers was then 
used to identify B cells (CD19+) and mast cells (CD117+). The 
number of events of each population was quantified and used 
to calculate the percentage of immune cells (CD45+) from the 
whole singlet cell population and the percentage of each immune 
cell population from the CD45+ immune cell subset (online 
supplemental figure 1B).
Histology and imaging mass cytometry
Samples were stained with H&E for determination of the 
degree of tendinopathy as assessed by a modified version of the 
Bonar score (grade 4=marked tendinopathy, grade 3=advanced 
tendinopathy, grade 2=moderate degeneration, grade 1=mild 
Table 1 Patient demographics for by imaging mass cytometry (IMC),flow cytometry (FACS) and single cell RNA- seq (scRNASeq)
Experiment Tissue Patients (n) Mean age in years (range) Sex (M:F)
Mean duration of 
symptoms in months 
(range)




5 58.6 (49–62) 2:03 6.4 (2–12) 1.3
FACS Supraspinatus tendinopathy
(established tendinopathy)




9 59.2 (46–63) 5:04 8.3 (4–13) 1.1
Control tendon
hamstrings tendon)
4 21.5 (19–25) 3:01 – –
scRNASeq Supraspinatus tendinopathy
(established tendinopathy)
4 62 (58–68) 2:02 6.2 (2–12) 1
Control tendon
(hamstrings tendon)
5 25 (21–28) 3:02 – –
 on M









is: first published as 10.1136/annrheum





3Garcia- Melchor E, et al. Ann Rheum Dis 2021;0:1–11. doi:10.1136/annrheumdis-2020-219335
Miscellaneous
degeneration, grade 0=normal tendon). This included the 
presence or absence of oedema and degeneration together with 
the degree of fibroblast cellularity and chondroid metaplasia. 
Examples of H&E staining used in imaging mass cytometry 
(IMC) are provided in online supplemental figure 2A. Tissues 
were immediately fixed in 4% formalin for 4–6 hours and then 
embedded in paraffin. Sections were cut to 5 µM thickness 
using a Leica- LM microtome (Leica Microsystems, Germany) 
and placed onto Superfrost Ultra Plus glass slides (Gerhald 
Menzel, Germany). Samples were stained with the following 
antibodies: anti- human CD4 (EPR6855)—156Gd, anti- human 
CD68 (KP1)—159Tb, anti- human CD8a anti- human collagen 
type I (Polyclonal)—169Tm, anti- human CD3 (Polyclonal, 
C- Terminal)—170Er, anti- histone 3 (D1H2)—176Yb (all Flui-
digm UK), using the IMC Staining Protocol for FFPE Sections 
from the manufacturer. Briefly, slides were baked for 2 hours 
at 60°C and then dewaxed in fresh xylene for 20 min followed 
by hydrating in descending grades of ethanol (100%, 95%, 
80%, 70%), 5 min each. They were washed in MAXpar water 
(Fluidigm) and then placed into preheated antigen retrieval 
solution (pH9) (Agilent) and incubated for 30 min at 96°C. 
Slides were cooled and washed in Maxpar water and Maxpar 
PBS (Fluidigm) twice and blocked for 45 min with 3% BSA 
(Sigma- Aldrich), following staining with antibodies previously 
mentioned in 3%BSA overnight. After that slides were washed 
in Maxpar PBS and then Maxpar water prior to drying. Sections 
were then ablated on Hyperion Imaging System (Fluidigm) for 
analysis. Data were exported to MCD viewer (Fluidigm) and 
images converted to allow cell segmentation using Cell Profiler 
and Ilastik (Broad Institute). HistoCat (BodenMiller) and 
IMACytE (Leiden) was used for unsupervised clustering of cells 
(PhenoGraph function) and neighbouring cells were defined as 
those within four pixels.
Single-cell RNA-seq
Single- cell suspensions of cells were derived from freshly 
digested tendon biopsies following surgical excision, as previ-
ously described.26 Live cells were sorted using a FACS ARIA 
III. Isolated cells (13 561 cells from healthy and 38 040 cells 
from supraspinatus tendon tissue) were lysed and then RNA was 
reverse- transcribed and converted to cDNA libraries for RNA- 
seq analysis using a Chromium Controller and Chromium Single 
Cell 3′ v2 Reagent kit (10x Genomics) following the manufac-
turer’s protocol. Pooled libraries were used for sequencing on 
a HiSeq 4000 (Illumina) to a depth of ~30 000 reads per cell. 
Alignment of reads to the genome and generation of gene counts 
per cell were performed by Cell Ranger software (10x Genomics). 
4080 cells from healthy and 22 004 cells from supraspinatus 
tendon tissue were sequenced. Quality control was performed 
on each sample and poor- quality cells were removed on the basis 
of number of genes expressed (<200), of unique molecular iden-
tifiers and percentage of mitochondrial reads mapped (>5%). 
Following this quality check (QC), we normalised and scaled the 
data using Seurat Package (Satija Lab) for all the cells (health 
k=3040, supraspinatus k=19 084). Then principal components 
analysis and high- quality cells were clustered using a graph- 
based routine implemented in Seurat R package and its inte-
gration method for multiple samples (Satija Lab). All cells from 
the tissue were clustered (online supplemental figure 1C), and 
immune cells were computationally isolated for further analysis 
(online supplemental figure 1D).
Stimulation of tenocytes
Healthy hamstring tendon tissue from ACL reconstructions was 
cut in small pieces with a scalpel and transferred into flasks with 
complete RPMI (RPMI media supplemented with 10% FBS, 
penicillin 100 IU/mL, streptomycin 100 µg/mL), which were 
placed in an incubator at 37°C, 5% CO2. After 24 hours, 1 mL 
of this conditioned media obtained from damaging the tendon 
was stored at −20°C until use. Tenocytes were seeded into 24 
well tissue culture plates (25 000 cells/well) and left to rest for 72 
hours at 37°C, 5% CO2. On day 3, media was replaced with fresh 
complete RPMI and cells were stimulated with 1 ng/mL IL-1β 
(Biolegend) or conditioned media from damaged tendon tissue. 
After 4 hours, media was removed and 300μL of cell lysis buffer 
(Life Technologies) was added to each well. Cell lysates were 
stored at −20°C for subsequent assessment of RNA expression.
Cell migration
In order to generate conditioned media from tenocytes to induce 
migration of T cells, tenocytes were stimulated as previously 
indicated with IL-1β for 4 hours and then washed twice with 
PBS. Cells were then kept in fresh complete RPMI media for 18 
hours, when media was collected and stored at −20°C.
Peripheral blood mononuclear cells (PBMCs) were obtained 
from healthy donors’ buffy coats from the Scottish National 
Transfusion Centre after centrifugation with a density gradient 
(Ficoll- Paque PLUS, GE Healthcare) and CD3+ cells were 
isolated using negative selection (Stemcell Technologies, Canada). 
T cells were pre- activated overnight with antibodies against 
CD3 (aCD3, 1 µg/mL, Biolegend) and CD28 (aCD28, 2 µg/mL, 
Biolegend). A transwell membrane system (5 µM, Corning) was 
used to assess the migration of 0.5×106 T cells per well placed 
in the upper chamber. Conditioned media from tenocytes was 
diluted to 80% in complete RPMI. After 4 hours, cells migrating 
to the lower chamber were counted with a haemocytometer and 
stained for FACS analysis.
Coculture of tenocytes and T cells
25 000 tenocytes were cocultured with 250 000 T cells (1:10 
ratio) obtained after CD3 positive selection (Miltenyi Biotec, 
Germany) from buffy coats, comparing direct contact between 
tenocytes and T cells with the effect of soluble factors in cocul-
tures in which a transwell membrane (0.4 µM, Corning) was 
used to keep both populations apart. After 48 hours, T cells were 
removed and stained for analysis of the activation marker CD69 
by FACS. Supernatants were stored for quantification of IFN-γ 
by ELISA (Invitrogen, California, USA). Tenocytes were washed 
twice with PBS in order to remove T cells and then lysed for 
analysis of gene expression.
Assessment of T cell activation by FACS
Surface expression of CD69 in T cells was used as a marker of 
T cell activation. T cells obtained from coculture experiments 
were transferred to 5 mL polystyrene tubes and washed with 
PBS. Viability staining was performed with efluor 506 viability 
dye (Thermo Fisher) for 15 min at 4°C in the dark. After one 
wash with FACS buffer (PBS+2% FBS), cells were stained for 30 
min at 4°C in the dark with the following antibodies: anti- CD3 
Pacific Blue, anti- CD4 PE- Cy7, anti- CD8 APC- Cy7, anti- CD69 
APC (Biolegend). After incubation, cells were washed once more 
and fixed with Cell Fix (Becton Dickinson) for 20 min at room 
temperature. Samples were run in an LSRII flow cytometer (BD 
Biosciences) and results analysed with FlowJo software.
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Assessment of gene expression
Cells were placed in lysis buffer containing 1% of β-mercap-
toethanol and a column system was used for RNA isolation 
according to manufacturer’s instructions (Life Technologies). 
Quantification and quality assessment of RNA was performed 
by spectrophotometry (Nanodrop 2000, Invitrogen, California, 
USA), cDNA was prepared with High Capacity cDNA reverse 
transcription kit (Invitrogen) and diluted 1 in 5 using RNase- 
free water. Real time PCR was performed in duplicate for each 
sample using SYBR green Master mix (Applied Biosystems, Cali-
fornia, USA) and results were normalised using 18S as house-
keeping gene. Primers (Integrated Technologies, Belgium) are 
listed in table 2.
Statistical analysis
Data are showed as mean±SEM. Normality of samples was 
assessed using Shapiro- Wilks, D’Agostino and Pearson or 
Kolmogorov- Smirnov tests, depending on the sample size, as 
provided by GraphPad Prism software. In tenocyte stimula-
tions, statistical analysis was performed using paired Student’s 
t- test or Wilcoxon matched- pairs signed rank test depending 
on normality. Friedman test with Dunn’s multiple comparison 
test was used for percentage of migration and one- way analysis 
of variance (ANOVA) and Dunnett’s multiple comparison test 
for CD4 and CD8 data in migration experiments; in both cases 
taking media condition as control. For coculture experiments 
CD69 analysis was performed also with one- way ANOVA but 
Tukey’s multiple comparisons test to allow comparison between 
all groups and for IFN-γ analysis Friedman’s test with Dunn’s 
multiple comparisons test due to lack of normality of data. 
Finally, for analysis of gene expression in cocultures, two- way 
ANOVA with Sidak’s multiple comparisons test was used. In all 
analyses p<0.05 was considered statistically significant.
RESULTS
Transcriptomic analysis and spatial distribution of T cells in 
tendinopathic tissue
First, we assessed the presence on T cells in tendinopathy. Torn 
supraspinatus (late tendinopathy) or intact subscapularis (early 
tendinopathy) biopsies from patients with rotator cuff tears were 
analysed by FACS. CD45+ immune cells were more frequent 
in late tendinopathy (16.34%±4.23 %, mean±SEM) compared 
with control healthy tendon (3.18%±1.03%, mean±SEM) 
(figure 1A). As previously described myeloid (CD64+) were the 
predominant immune cell in tendinopathic tissue (online supple-
mental figure 1B). Interestingly, T cells were present in healthy 
tendon, and this population increased in tendinopathic tissues 
(figure 1A) suggesting the potential for an adaptive response 
throughout the spectrum of tendon disease.
Accordingly, we employed IMC to map the geographical 
location of immune cells in tendinopathic tissues (figure 1B and 
online supplemental figure 2B). Spatially there was no consistent 
evidence of immune cell (T cells CD3+ or macrophages CD68+) 
clustering in tendinopathic tissue. Both CD3+ and CD68+ cells 
were primarily interspersed adjacent to tenocytes (Col1high) in 
tendinopathic tissue suggesting tendon immune cell interactions. 
Further neighbourhood analysis of this data demonstrated that 
both T cells and macrophages were present around Col1a posi-
tive cells (online supplemental figure 2C).
The presence of T cells in tendon tissue was also assessed by 
single cell RNA- sequencing from healthy and tendinopathic 
tendon. Once again, T cells were detected in both healthy and 
diseased tendon (figure 1C and online supplemental figure 1D). 
The proportion of T cells in the total immune compartment 
of tendinopathic tissues (12.23%) was greater than in normal 
tendon (7.93%) (figure 1C). Furthermore, T cells from tend-
inopathic tissue had greater expression of a number of genes 
associated with T cell activation such as CXCR3, CCL5, LGALS1 
(Galectin-1), IL2RG, CD74, CD52 and IL-3227–31 (figure 1D). 
We also observed genes associated with residency (increase in 
TGFB1, NR4A1, PRDM1 and decrease of KLF2)32 in T cells 
from healthy tendon and active proliferation (MKI67, PTTG1) 
in diseased tissue (online supplemental figure 3).
Taken together, these data demonstrate the presence of T 
cells in normal tendon with greater proportion present in tend-
inopathy associated with an overall inflammatory response in 
damaged tendon which may be due to proliferation, migration 
or a combination of both.
Activated tenocytes upregulate inflammatory cytokines and 
chemokines involved in T cell recruitment
Damaged human tendon explants represent an ideal model to 
explore the pathways whereby tendinopathic pathogenesis may 
be perpetuated. Accordingly, conditioned media obtained from 
exogenously damaged healthy hamstring tendon was used to 
stimulate healthy primary tenocytes (figure 2A). After 4 hours, 
we observed upregulation in gene expression of inflammatory 
cytokines (IL1B, IL6), chemokines (IL8, CCL2 and CCL5) and 
adhesion molecules (ICAM1) involved in the recruitment of 
immune cells (figure 2B). The same effect was observed after 
activation of tenocytes with IL-1β, which also enhanced the 
transcription of chemokines capable of T cell recruitment, such 
as CCL533 (figure 2C). Thus, the presence of tendon damage 
is able to activate adjacent tenocytes, rendering primary human 
tenocytes permissive to T cell recruitment and activation.
Tenocytes induce T cell migration
We next interrogated the effect of activated tenocytes on T cell 
migration using a transwell system. As in vivo activation of T cells 
preferentially takes place in regional lymph nodes before subse-
quent migration into tissue, T cells were preactivated overnight 
with anti- CD3 and anti- CD28 antibodies and then loaded on top 
Table 2 Table of primers
Gene Primers
18S 5′-GTA ACC CGT TGA ACC CCA TT-3′ (F)
5′-CCA TCC AAT CGG TAG TAG CG-3′ (R)
IL1B 5′-CAC CTG TAC GAT CAC TGA ACT G-3′ (F)
5′-AAC ACC ACT TGT TGC TCC ATA-3′ (R)
IL6 5′-CAC TCA CCT CTT CAG AAC GAA T-3′ (F)
5′-GCT GCT TTC ACA CAT GTT ACT C-3′ (R)
IL8 5′-GTG CAT AAA GAC ATA CTC CAA ACC-3′ (F)
5′-GCT TTA CAA TAA TTT CTG TGT TGG C-3′ (R)
CCL2 5′-CTC AGC CAG ATG CAA TCA ATG-3′ (F)
5′-TGC TGC TGG TGA TTC TTC TAT-3′ (R)
CCL5 5′-GCT GCT TTG CCT ACA TTG C-3′ (F)
5′-CTT TCG GGT GAC AAA GAC GA-3′ (R)
CXCL10 5′-CAC GTG TTG AGA TCA TTG CTA C-3′ (F)
5′-CCT TGC TAA CTG CTT TCA GTA AAT-3′ (R)
ICAM1 5′-AGC TTC TCC TGC TCT GCA A-3′ (F)
5′-GGG CCA TAC AGG ACA CGA A-3′ (R)
COX2 5′-CAA ATT GCT GGC AGG GTT G-3′ (F)
5′-GGT CAA TGG AAG CCT GTG ATA-3′ (R)
COL1A 5′-CAA TGC TGC CCT TTC TGC TCC-3′ (F)
5′-CAC TTG GGT GTT TGA GCA TTG-3′ (R)
COL3A 5′-TAT CGA ACA CGC AAG GCT GTG-3′ (F)
5′-GGC CAA CGT CCA CAC CAA ATT-3′ (R)
 on M
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of a transwell membrane, while conditioned media from teno-
cytes with or without previous activation with IL-1β was placed 
below the membrane (figure 3A). After 4 hours, the number of 
migrated T cells was counted (figure 3B) and the proportion of 
CD4+ and CD8+ cells analysed by FACS (figure 3C). Superna-
tants from tenocytes, particularly after activation, promoted the 
migration of T cells as shown by an increase in the percentage 
of migration (negative control 15.45±1.35, conditioned media 
from resting tenocytes 19.07±1.68, conditioned media from 
activated tenocytes 24.3±2.13, data expressed as media±SEM, 
negative control vs activated tenocytes p=0.003) without pref-
erential recruitment of CD4+ or CD8+ cell subset proportions. 
This supports the notion that after tissue damage, tenocytes 
produce chemokines that recruit polyclonal T cells into tendon.
Direct contact of tenocytes with T cells results in further 
activation of T cells
To assess if tenocytes can further amplify the inflammatory 
response, we interrogated their ability to maintain a T cell 
activation state. T cells isolated from PBMCs were cocultured 
with healthy explanted tenocytes with or without a transwell 
membrane, the latter to assess the requirement for cell–cell 
membrane interactions (figure 4A). We used two methods for 
isolation of T cells from peripheral blood, negative or positive 
selection. We also tested the contribution of antigen presenting 
cells (APC) to the system by adding aCD28. After 48 hours, T 
cells were harvested and CD69 expression and IFN-γ production 
were used to assess T cell activation. We observed that coculture 
of T cells with tenocytes lead to significant increase in activation 
Figure 1 Presence of T cells in tendinopathy. (A) Flow cytometry analysis showing percentage of immune cells (CD45+) and proportion of CD3+ 
cells in healthy, subscapularis (early tendinopathy) or supraspinatus (late tendinopathy) tendon tissues, n>4, *p≤0.05. (B) Imaging mass cytometry 
images obtained from analysis of representative supraspinatus tendon sections. Small squares show magnification of the area where T cells and 
tenocytes interact (white arrow). (C) UMAP of immune cells from tendon tissue following single cell sequencing data from five normal tendons 
(k=1110) versus four supraspinatus tendons (k=2568). Bar graph shows the percentage of myeloid and T cell populations from total immune cells. (D) 
Dot plot displaying expression of genes associated with T cell activation from the T cell population in the tendon.
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of T cells as assessed by increased CD69 expression and IFN-γ 
release, especially when T cells were isolated by positive selec-
tion (figure 4 and online supplemental figure 4A). This effect 
primarily required cell contact between T cells and tenocytes, 
since it was substantially reduced by transwell cell separation 
(mean percentage CD69+ cells±SEM; direct contact T cells 
12.94±1.2, T cells with aCD28 38.45±2.3, T cells with aCD28 
and tenocytes 90.51±0.83 versus transwell system T cells 
18.74±2.11, T cells with aCD28 59.39±2.888, T cells with 
aCD28 and tenocytes 61.63±1.036). Interestingly, this required 
the presence of anti- CD28, as in its absence IFN-γ levels were 
undetectable (online supplemental figure 5). This observation 
may suggest that T cells preactivated in the lymph node by APC 
such as dendritic cells migrate to the damaged tendon tissue 
Figure 2 Tenocytes in the context of damage upregulate inflammatory cytokines, chemokines and adhesion molecules. (A) For the obtention of 
conditioned media from damaged tendon, healthy tendon tissue was cut and transferred into a cell culture flask with complete RPMI for 24 hours. 
One millilitre of this conditioned media containing products from damaged tissue was then stored and used to stimulate healthy tenocytes. (B) 
Changes in gene expression of tenocytes from two different healthy tendons after 4- hour stimulation with four different explant conditioned media, 
graphs show mean±SEM. Statistical analysis comparing mean values of explant stimulation in each tenocyte with unstimulated using paired t- test. 
(C) Healthy tenocytes were stimulated with interleukin-1β for 4 hours (n=5). Statistical analysis using paired t- test or Wilcoxon matched- pairs signed 
rank test depending on normality. Graphs show 2−ΔCt after normalisation with the house- keeping gene 18S and fold change in gene expression is 
relative to unstimulated. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.
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where they are further activated after the contact with tenocytes 
or alternatively are activated by CD80+ or CD86+ myeloid 
cells in the tendon.
Activated T cells induce the expression of inflammatory 
cytokines and chemokines in tenocytes
We finally interrogated the reciprocal effect that infiltrating T 
cells may exert on the stromal compartment by analysing changes 
in gene expression of tenocytes cocultured with activated T cells. 
After coculture with T cells, we observed an upregulation of 
inflammatory mediators (IL-6, COX2) and chemokines (IL-8, 
CCL2, CCL5, CXCL10) (figure 5A) compared with tenocytes 
alone. This was particularly evident following direct contact 
between tenocytes and T cells. Exceptions were CCL2 and 
CXCL10 that were equally upregulated in the presence of the 
transwell membrane. Coculture of tenocytes and T cells also 
modulated collagen production, increasing the COL3/COL1 
ratio. This effect on the stroma required T cells to be activated, 
as negative selection of lymphocytes from PBMCs resulted in 
less activation of T cells when cocultured with tenocytes and no 
effect on the gene expression of tenocytes (online supplemental 
figure 4B).
DISCUSSION
Emerging evidence supports the role that stromal cell functions 
extend beyond the maintenance of tissue architecture, playing 
a key role in choreographing immune responses and thereby 
defining disease persistence.34 In line with this concept, we 
hypothesised that the interaction between tenocytes and the 
infiltrating population of immune cells could shape the outcome 
of the inflammatory response in tendinopathy, leading to resolu-
tion or chronicity. Our results demonstrate that in the context of 
tendon damage, tenocytes upregulate genes involved in inflam-
mation and T cell recruitment and are able to induce migration 
of activated T cells in vitro. Direct contact of T cells with teno-
cytes resulted in further activation of these T cells, that in turn 
upregulated the expression of inflammatory cytokines, chemo-
kines and favoured collagen 3 over collagen 1 in the stromal 
compartment, creating a feedback loop that may contribute to 
the establishment of a chronic inflammatory response(figure 6).
Whereas some studies have failed in the past to demonstrate 
the presence of an inflammatory infiltrate in tendinopathic 
tissues by immunohistochemistry,35–39 we and others have 
previously reported the presence of T cells and other immune 
cells.8 In the present study we confirmed the presence of T cells 
Figure 3 Conditioned media (CM) from activated tenocytes promotes the migration of T cells. (A) T cells were preactivated overnight with anti- CD3 
(1 µg/mL) and anti- CD28 (2 µg/mL) antibodies. A transwell membrane system was then used to assess the migratory effect of CM from tenocytes with 
or without previous activation with interleukin-1β on these activated T cells. (B) Percentage of T cells that migrate through the transwell system after 
4 hours. (C) Assessment of CD4+ and CD8+ populations (percentage from total cells that migrate and absolute number of cells) on the migratory 
fraction by flow cytometry. Data are shown as mean±SEM. Results from two independent experiments with a total of five different tenocyte 
conditioned media. Statistical analysis using one- way analysis of variance (ANOVA) and Dunnett’s multiple comparison test for CD4 and CD8 data and 
Friedman test with Dunn’s multiple comparison test for percentage of migration; in both cases taking media condition as control; *p≤0.05, **p≤0.01, 
***p≤0.001, ****p≤0.0001.
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in tendinopathy by FACS analysis and single- cell RNA seq of 
tendon supraspinatus samples from patients with rotator cuff 
tears undergoing surgery. Our results support the recent observa-
tion by Kendal et al of the presence of T cells in chronic tendon 
disease tissue by CITE- seq.12 IMC allowed us to assess the infil-
tration of T cells, both CD4+ and CD8+, supporting the idea 
of tenocyte–T cell interactions in vivo. Our results could also 
have implications in other rheumatic disorders such as SpA. In 
psoriatic arthritis for example, damage or mechanical stress in 
the tendon has been proposed as the starting point in the devel-
opment of local inflammation at enthesial sites (attachments 
of tendons, ligaments and capsules to bones) or enthesitis, that 
further evolves to joint inflammation or synovitis through what 
has been referred as ‘synovio- enthesal complex’.40 Recently, 
Watad et al reported the presence of T cells in healthy enthe-
seal tissue,25 supporting our finding of a population of T cells 
in healthy tendon tissue. Understanding which factors govern 
the interaction of T cells with the tendon stroma could help 
to develop targeted therapies to avoid a chronic inflammatory 
response.
In order to model the microenvironment that may be present 
in tendinopathy, we stimulated healthy tenocytes in vitro with 
conditioned media obtained from tissue explants in which 
tissue has been previously disrupted, therefore containing a 
milieu of inflammatory mediators and cell debris mimicking 
damaged tendon. Stimulation of tenocytes with this condi-
tioned media or IL-1β, a cytokine involved in sterile inflam-
mation, resulted in an upregulation of inflammatory cytokines 
and chemokines. Stolk et al,41 using conditioned media from 
anti- CD3 and anti- CD28 stimulated PBMC cultures, observed 
an upregulation of adhesion (ICAM-1, VCAM-1) and HLA 
molecules (HLA- ABC, HLA- DR) and IL-6 and when stimu-
lated with IL-1β, tenocytes increased their production of IL-6, 
IL-8 and CCL2. Together, these results support the role of 
tenocytes as sensors of damage and their ability to participate 
in the inflammatory response.
Figure 4 Direct contact of T cells with tenocytes further increases T cell activation. (A) Two different systems were used to coculture tenocytes 
and T cells (1:10 ratio) for 48 hours; in direct cocultures tenocytes and T cells were in the same well in contact with each other, whereas on the 
transwell system a membrane was placed between both populations. T cell activation was assessed by CD69 expression by flow cytometry (FACS) 
and interferon (IFN)-γ production in supernatants by ELISA in both direct (B) and transwell (C) cocultures. Histograms show CD69 expression in 
unstimulated T cells (grey line), T cells with anti- CD28 (black line) and T cells with anti- CD28 cocultured with tenocytes (dotted line). Results from 
four independent experiments, each one with a different healthy T cell donor. A total of six different healthy control tenocytes were used. IFN-γ was 
quantified in two of the experiments. Graphs show data as mean±SEM, statistical analysis using one- way analysis of variance (ANOVA) and Tukey’s 
multiple comparisons test or FACS data and Friedman’s test with Dunn’s multiple comparisons test for IFN-γ due to lack of normal distribution, 
*p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.
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This inflammatory response that takes place after damage 
usually resolves as infiltrating cells are cleared through induc-
tion of apoptosis and phagocytosis by macrophages whereas on 
the other side chronicity is characterised by the persistence of 
immune cells. Growing evidence supports the role of an acti-
vated or pathogenic stroma in the maintenance of this inflamma-
tory infiltrate and the development of chronic inflammation,42 
with inflamed tissue expressing inflammatory cytokines, chemo-
kines and adhesion molecules that can lead to migration, reten-
tion and survival of leukocytes. After activation in lymph nodes 
by APC, T cells upregulate CCR5 and CXCR3 allowing them to 
enter inflamed tissues.43 In our system we observed that teno-
cytes were able to upregulate chemokines involved in T cell 
recruitment such as CCL5 and CXCL10, that are known ligands 
of CCR5 and CXCR3, and induce T cell migration, particularly 
when previously activated with IL-1β. Coculture of tenocytes 
with T cells resulted in activation of T cells, which notably was 
contact dependant. To our knowledge this is the first study to 
investigate the direct interaction between tenocytes and T cells. 
Previous published work has demonstrated that coculture of 
macrophages with tenocytes results in an increased IL-6, IL-8 
and MCP-1 and CD80 expression on macrophages41 and in this 
case cell contact was not required. In our experiments, cytokines 
(IL-1β, TNF-α, IL-15) or adhesion molecules such as LFA-1 in 
T cells and ICAM-1 on tenocytes could have a key role in these 
cellular interactions.44 45
Once activated, T cells also had an effect on tenocytes, with the 
upregulation of IL-6, IL-8, COX2, CCL2, CCL5 and CXCL10 
in tenocytes. Of interest, this effect was observed when T cells 
were fully activated. This requirement of T cell activation has 
already been described, as membranes from T cells previously 
activated with leukophytohaemagglutinin and phorbol myristate 
Figure 5 Differential effect of activated T cells on tenocytes. (A) Changes in gene expression of tenocytes after coculture with T cells+anti- CD28 for 
48 hours with or without the presence of a transwell membrane to prevent cell contact. Graphs show mean±SEM of 2−ΔCt values after normalisation 
with the house- keeping gene 18S. (B) Ratio between 2−ΔCt values of COL3 and COL1. Results from three independent experiments involving three 
different T cell donors and four different tenocyte donors. Statistical analysis using two- way analysis of variance (ANOVA) with Sidak’s multiple 
comparisons test, *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.  on M
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acetate were able to induce MMP-1 and PGE2 production in 
dermal and synovial fibroblasts46 and type II collagen stimulated 
T cells induced the production of IL-17, TNF-α and IL-18 while 
cocultured with RA synovial fibroblasts.21 Of note, the pres-
ence of T cells increased collagen 3 proportion, which is one of 
the pathological features of tendinopathy and that results in a 
tendon with inferior biomechanics.1
There are limitations inherent in our study. Age- related 
changes within the tendon samples could contribute to the 
degenerative picture and inflammatory cell expression seen in 
late tendinopathy. However, the lack of degenerative changes 
on MRI and arthroscopic examinations suggests that the differ-
ences are truly at the cellular level as suggested by our previous 
work.14 Being an in vitro study, we are analysing the interaction 
between tenocytes and T cells, excluding other factors such as 
matrix proteins or other immune cells that could also modulate 
this relationship and the inflammatory process. Accordingly, in 
our system T cell activation in coculture with tenocytes required 
the presence of anti- CD28 that in vivo could be provided by 
other cells such as dendritic cells. Also, we need to take into 
consideration the effect of an allogenic response in our coculture 
experiments, although we did not observe differences regarding 
tenocyte cell death. Further mechanistic investigation in an in 
vivo tendon injury model could further address the relevance of 
the adaptive immune response in tendon pathogenesis.
CONCLUSION
Our study establishes a previously unrecognised relationship 
between T cells and stromal cells in human tendon disease. This 
interaction results in the upregulation of inflammatory cytokines, 
chemokines and adhesion molecules in activated tenocytes and is 
also associated with changes in collagen composition, supporting 
the concept that the adaptive immune response plays a crucial 
role in a biomechanically associated disease such as tendinop-
athy. Therefore, selectively targeting T cell signalling in disease 
provides scope for novel translational strategies in the manage-
ment of tendon disorders and other enthesial pathologies.
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Figure 6 Proposed mechanism of T cell activation after tendon damage. Mechanical stress in the tendon, directly or through the release of 
endogenous damage- associated molecular patterns (DAMPs) would result in the activation of tenocytes. Once activated, they would produce 
inflammatory cytokines, chemokines and upregulate adhesion molecules in their surface in order to initiate an immune response to repair the tendon 
damage. In parallel, antigen presenting cells such as dendritic cells would become activated locally and migrate to the lymph node where they will 
activate T cells that would migrate to the injured tissue guided by a gradient of chemokines produced after tendon damage. The contact between 
tenocytes and T cells would further activate these T cells, which in turn amplificate the inflammatory response and promote changes in tendon matrix. 
IL, interleukin; TLR, toll like receptor.
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Supplemental Figure 1. Presence of T cells in tendinopathy. (A) Representative FACS plots from disease tissue 
demonstrating gating strategy to identify immune cell populations in disaggregated tissue. (B) Analysis of the presence 
of immune cells in tendinopathy by FACS. (C) UMAP of cells isolated from tendon following single cell sequencing 
identifying endothelial cell (PECAM1), muscle cells (MYF5), myofibroblasts (ACTA2) and immune cells (PTPRC, 
MARCO, CD3D), data from 5 normal tendons and 4 supraspinatus tendons (k=22124). (C) UMAP immune cells from 
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Supplemental Figure 2. Imaging mass cytometry (IMC) of supraspinatus  tendon. (A) H&E images of sections used 
for IMC, 4x magnification. (B) IMC image analysis of supraspinatus tendon section, percentage of CD4+ and CD8+ as 
measured via IMC, n=5. (C) Representative heatmap showing the z-scored mean marker expression of the panel 
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Supplemental Figure 4. Activation of CD3+ T cells isolated with negative selection in co-culture with tenocytes. 
Percentage of CD69+ cells after 48 hours of culture with or without tenocytes assessed by FACS (A) and changes 
in transcripts on tenocytes (B) in these co-cultures. T cells were isolated from healthy controls PBMCS using a negative 
selection method. Results from 3 independent experiments, each one with one T cell donor and 2 tenocyte donors. 
Graphs show data as mean +/- SEM, statistical analysis using one-way ANOVA and Holm-Sidak’s multiple comparisons test
for CD69 and 2-way ANOVA with Sidak’s multiple comparisons test for gene expression analysis in two independent 
experiments, (*) p ≤ 0.05, (**) p ≤ 0.01, (***) p ≤ 0.001, (****) p ≤ 0.0001.
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